The first daily disposable silicone hydrogel soft contact lenses specifically designed for slowing the progression of myopia in children*1 has now launched in Australia.
Johnson & Johnson Vision (J&J) debuted ACUVUE Abiliti 1-Day Soft Therapeutic Lenses for Myopia Management at the Optometry Clinical Conference in Melbourne on 17-18 August 2025.
To mark the occasion, J&J hosted a breakfast session featuring presentations by Dr Emma Gillies and Mr Alex Petty on the novel optics, paediatric design, and key features and benefits of Abiliti 1-Day.
Petty, principal optometrist and director of Bay Eye Care, shared real-world examples of how the lens is directly impacting his patient care and myopia management practice.
Attendees learned that Abiliti 1-Day lenses are inspired by the paediatric eye,¥2 with a smaller diameter for improved insertion and removal, and made from the same silicone hydrogel material as ACUVUE OASYS 1-Day.3
Featuring J&J’s RingBoost technology,1 Abiliti 1-Day has shown to be ~2X as effective at managing myopia compared to a dual focus lens,§˄4 the company said. Furthermore, nearly 65% of children’s eyes wearing Abiliti 1-Day showed little to no myopia progression† over the course of two years.4
A few days later, J&J hosted a virtual webinar during which more than 1,000 viewers tuned in to hear presentations from Associate Professor Noel Brennan, Dr Xu Cheng and Petty on the technology and impact of Abiliti 1-Day.
Optometrists interested in adding Abiliti 1-Day to their myopia management toolkit can take the first step by completing the ACUVUE® Abiliti 1-Day Accreditation Program on JNJVISIONPRO.
Click here for Australia and click here for New Zealand
References and disclaimers
* Based on publicly available information as of December 3, 2021.
¥ utilising a smaller lens diameter designed to git the smaller anatomical features of a paediatric population (aged 7-12)‡ www.clinicaltrials.gov is a website maintained by the NIH. The 5 clinical studies evaluated subjective comfort as a primary or secondary endpoint for ACUVUE OASYS Brand daily disposable family. Review conducted as of October 29, 2021.
* Based on axial elongation after 6 months of wear.
˄ Senofilcon A prototype dual focus lens.
† Change in Spherical Equivalent of Cycloplegic Auto Refraction ≥-0.25 D\
1. JJV Data on file, 2021. Development of Optical Design of ACUVUE® Abiliti® 1-Day Soft Therapeutic Lenses for Myopia Management.
2. JJV Data on File 2021. Mechanical Design of ACUVUE® Abiliti® 1-Day Soft Therapeutic Lenses for Myopia Management – Effect on Fit and Handling.
3. JJV Data on File 2021. Stand-Alone Performance Claims – ACUVUE® Abiliti® 1-Day Soft Therapeutic Lenses for Myopia Management.
4. JJV Data on file, 2021. Efficacy of ACUVUE® Abiliti® 1-Day Soft Therapeutic Lenses for Myopia Management: Comparative Claims vs. Single Vision and Dual Focus Lenses.
